- Home
- FBIO
FBIO
Fortress Biotech Inc.
as 03-28-2025 4:00pm EST
| Founded: | 2006 | Country: | United States |
| Employees: | N/A | City: | BAY HARBOR ISLANDS |
| Market Cap: | N/A | IPO Year: | N/A |
| Target Price: | $21.00 | AVG Volume (30 days): | 370.9K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 3 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -3.39 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.36 - $2.89 | Next Earning Date: | 05-14-2025 |
| Revenue: | $81,501,000 | Revenue Growth: | 31.52% |
| Revenue Growth (this year): | -28.97% | Revenue Growth (next year): | 128.63% |
Latest Fortress Biotech Inc. News
FBIO Breaking Stock News: Dive into FBIO Ticker-Specific Updates for Smart Investing
GlobeNewswire
a day ago
Checkpoint Therapeutics Reports Full-Year 2024 Financial Results and Recent Corporate Updates
GlobeNewswire
3 days ago
Journey Medical Corporation Reports Full-Year 2024 Financial Results and Recent Corporate Highlights
GuruFocus.com
4 days ago
Fortress Biotech Inc (FBIO) Q4 2024: Everything You Need To Know Ahead Of Earnings
GlobeNewswire
5 days ago
Journey Medical Corporation Launches Emrosi™ (40 mg Minocycline Hydrochloride Modified-Release Capsules, 10 mg immediate release and 30 mg extended release) for the Treatment of Rosacea
GlobeNewswire
10 days ago
Journey Medical Corporation to Announce Year End 2024 Financial Results on March 26, 2025
MT Newswires
12 days ago
Sector Update: Health Care Stocks Gain Monday Afternoon
MT Newswires
12 days ago
Fortress Biotech, Partex Team Up for Asset Identification, Evaluation Using AI
GlobeNewswire
12 days ago
Partex and Fortress Biotech Announce Strategic Collaboration to Accelerate Asset Identification and Evaluation Using Proprietary AI Platform
Compare FBIO vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "FBIO Fortress Biotech Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.